Article
Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?
International journal of immunogenetics - 1 Aug 2015
Dickinson A M, Norden J
Abstract excerpt
Haematopoietic stem cell transplantation (HSCT) remains the only cure for many haematological neoplasms; however, the mortality rate remains high, at around 30-80%. Complications after HSCT include relapse, graft-versus-host disease, graft rejection and infection. High-resolution HLA matching has improved survival in HSCT over recent years; however, GVHD still remains a serious complication. Single nucleotide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
